micro News and Research

RSS

Silence Therapeutics receives patent for RNA silencing method

Silence Therapeutics plc announces the issuance of United States patent 7,772,203, titled "Methods and Compositions for Controlling Efficacy of RNA Silencing," by the United States Patent and Trademark Office (USPTO). The issued patent generally claims methods of enhancing RNA silencing with a double stranded RNA interference (RNAi) agent. The patent's RNA silencing method claims include coverage for the administering of a pharmaceutical composition containing short interfering RNA (siRNA), micro RNA (miRNA), pre-miRNA or short hairpin (shRNA) molecules. Silence believes the proprietary structural modification techniques covered in this patent will play a key role in increasing the potential therapeutic efficacy of RNAi therapeutics.

11 Aug 2010

Enriched breakfast re-energizes children's morning rituals and boosts learning potential

As the lazy days of summer vacation begin to come to a close, it's time to start thinking about re-formulating and re-energizing morning rituals that can help boost your child's learning potential.

11 Aug 2010

Opinions: HIV prevention research; Foreign aid; Sanitation; Aid, self-reliance

"Microbicides, vaccines and other new approaches will one day join proven HIV-prevention strategies, including condoms, male circumcision and clean needles. How soon that day comes will depend on whether funders and the scientific community can develop the more collaborative approaches to HIV prevention research needed to address this fast-moving epidemic," Global HIV Vaccine Enterprise leaders Alan Bernstein, executive director, and Peter Piot, chair, write in a Globe and Mail opinion piece.

11 Aug 2010

Africa needs policies, regulations to spur development of innovative mobile phone-based applications

The fast-growing use of cell phones in Africa - where many people lack the basic human necessities - has made headlines worldwide the past few years. The surprising boom has led to widespread speculation that cell phones could potentially transform the impoverished continent.

10 Aug 2010

New microchip technology to detect oral cancer

A new test for oral cancer, which a dentist could perform by simply using a brush to collect cells from a patient's mouth, is set to be developed by researchers at the University of Sheffield and Sheffield Teaching Hospitals NHS Foundation Trust.

10 Aug 2010

Taiyo Pacific Partners becomes third largest shareholder in CMIC

Taiyo Pacific Partners announced today that it has accumulated a position in excess of 5% in CMIC Co., Ltd. (2309) to become its third largest shareholder. Taiyo Pacific Partners is known for its cooperative investment style working with senior management to enhance shareholder value.

7 Aug 2010

Salamander research findings bring scientists closer to future regenerative therapies

Tissue regeneration in salamanders and newts seems like it should be the stuff of science fiction. But it happens routinely. Why can't we mammals just re-grow a limb or churn out a few new heart muscle cells as needed? New research suggests there might be a very good reason: Restricting our cells' ability to pop in and out of the cell cycle at will - a prerequisite for the cell division necessary to make new tissue - reduces the chances that they'll run amok and form potentially deadly cancers.

6 Aug 2010

New soft-tissue fillers for skin tightening, volume restoration in cheek area

Now, armed with a deeper understanding of full facial contouring, dermatologists are using soft-tissue fillers to enhance and restore volume loss in the cheek area, thereby smoothing nasolabial folds (the wrinkles that form along the bottom of the nose to the corners of the mouth). In addition, newly introduced fractional radiofrequency technology to address skin laxity is showing promise by stimulating collagen contraction and reducing loose skin in the lower-face.

6 Aug 2010

Definiens launches Tissue Studio 2.0 image analysis software for digital pathology

Definiens today announced the introduction of Definiens Tissue Studio™ 2.0, the latest version of the company's leading image analysis software for digital pathology.

4 Aug 2010

Biomedical engineering professor receives patent for Electromagnetic Probe Device

The United States Patent Office has issued a patent to Dr. Mark DeCoster, associate professor of biomedical engineering at Louisiana Tech University, for his invention of an "Electromagnetic Probe Device" - an innovative technology developed at Louisiana Tech's Institute for Micromanufacturing.

4 Aug 2010

Axiogenesis signs non-exclusive license agreement with iPS Academia

Axiogenesis AG and iPS Academia Japan Inc. (Kyoto, Japan) announced that they have executed a non-exclusive agreement with iPS Academia (Kyoto, Japan) through which Axiogenesis obtains worldwide access to the extensive portfolio of induced pluripotent stem cell technology for iPSC-derived cardiomyocytes and other cell types, pioneered by Professor Shinya Yamanaka, Center for iPS Cell Research and Application at the University of Kyoto, Japan.

3 Aug 2010

IntegenX selects Zeta's 3D to analyze dimensional properties of micro-channel biochips

Zeta Instruments, Inc. a leading provider of cost-effective, precision measurement solutions for micron-scale surface analysis, announced that its Zeta-20™ optical metrology system has been selected for the analysis and development of advanced microfluidics/biotechnology laboratory products. IntegenX, an innovative supplier of automation systems for DNA and RNA-based micro-sample preparation used in forensics and gene sequencing, has chosen Zeta's 3D surface measurement solution to analyze the dimensional properties of its micro-channel biochips.

3 Aug 2010

Rush University Medical Center first to receive Octapharma grant under anniversary program

Octapharma USA today announced the first grant recipient of the Octapharma 25th Anniversary Grants Program is the Rush Hemophilia & Thrombophilia Center at Rush University Medical Center. The Octapharma grants program supports clinical or pre-clinical research focused on human protein therapies in hematology, immune therapy, intensive care and emergency medicine.

3 Aug 2010

Biomaterials-based bone grafts can manipulate cell behavior to repair injury

Scientists have developed a material for bone grafts that could one day replace the 'gold standard' natural bone implants.A new study shows how particles of a ceramic called calcium phosphate have the ability to stimulate promising bone regrowth by attracting stem cells and 'growth factors' to promote healing and the integration of the grafted tissue.

3 Aug 2010

Scientists discover technique for more controlled lab experiments on cellular mechanobiology

Bioengineers at the University of Pennsylvania have created a system to control the flexibility of the substrate surfaces on which cells are grown without changing the surface properties, providing a technique for more controlled lab experiments on cellular mechanobiology, an important step in the scientific effort to understand how cells sense and respond to mechanical forces in their environment.

2 Aug 2010

Surgeons continue to advance minimally-invasive surgery for kidney cancer patients

Surgeons at the University of California, San Diego School of Medicine continue to advance minimally-invasive surgery for cancer patients by reducing the number of abdominal incisions from approximately six to a single small incision.

30 Jul 2010

Safeguard Scientifics second-quarter aggregate revenue of partner companies increase 47% to $91.6 million

Safeguard Scientifics, Inc., a holding company that builds value in growth-stage life sciences and technology companies, today announced that aggregate revenue of its partner companies for the three months ended June 30, 2010 was $91.6 million, up 47% from $62.3 million for the same partner companies in the same period of 2009. For the six months ended June 30, 2010, the aggregate partner company revenue was $176.9 million, up 45% from $121.8 million for the same partner companies for the same period of 2009.

29 Jul 2010

Circulating aberrant cells increase as non-small cell lung cancer progresses

A novel approach detects genetically abnormal cells in the blood of non-small cell lung cancer patients that match abnormalities found in tumor cells and increase in number with the severity of the disease, a research team led by scientists at The University of Texas MD Anderson Cancer Center report in the journal Clinical Cancer Research.

23 Jul 2010

AIDS 2010: Halving HIV/TB co-infection deaths; Financial transaction tax discussed, and more

UNAIDS and the Stop TB Partnership joined together on Thursday at the International AIDS Conference-AIDS 2010 in Vienna, Austria, with the goal of preventing 200,000 deaths annually from HIV and tuberculosis co-infection, Agence France-Presse reports. TB is the number one killer of people living with HIV/AIDS (Ingham, 7/22).

23 Jul 2010

Innovative imaging system uses night vision technology to tackle common side effect of cancer treatment

The University of Texas Health Science Center at Houston (UTHealth) has reached an agreement with other institutions that will allow it to take the next step in commercially developing an innovative medical imaging system that uses night vision technology to tackle a common side effect of cancer treatment.

16 Jul 2010

micro News and Research

Silence Therapeutics receives patent for RNA silencing method

Enriched breakfast re-energizes children's morning rituals and boosts learning potential

Opinions: HIV prevention research; Foreign aid; Sanitation; Aid, self-reliance

Africa needs policies, regulations to spur development of innovative mobile phone-based applications

New microchip technology to detect oral cancer

Taiyo Pacific Partners becomes third largest shareholder in CMIC

Salamander research findings bring scientists closer to future regenerative therapies

New soft-tissue fillers for skin tightening, volume restoration in cheek area

Definiens launches Tissue Studio 2.0 image analysis software for digital pathology

Biomedical engineering professor receives patent for Electromagnetic Probe Device

Axiogenesis signs non-exclusive license agreement with iPS Academia

IntegenX selects Zeta's 3D to analyze dimensional properties of micro-channel biochips

Rush University Medical Center first to receive Octapharma grant under anniversary program

Biomaterials-based bone grafts can manipulate cell behavior to repair injury

Scientists discover technique for more controlled lab experiments on cellular mechanobiology

Surgeons continue to advance minimally-invasive surgery for kidney cancer patients

Safeguard Scientifics second-quarter aggregate revenue of partner companies increase 47% to $91.6 million

Circulating aberrant cells increase as non-small cell lung cancer progresses

AIDS 2010: Halving HIV/TB co-infection deaths; Financial transaction tax discussed, and more

Innovative imaging system uses night vision technology to tackle common side effect of cancer treatment

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News